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Abstract 
Background: Exercise programmes that can demonstrate evidence of long-lasting 
clinical effectiveness are needed for people with multiple sclerosis (PwMS).  
Objective: The objective of this study was to assess the effects of a practically 
implemented exercise programme on self-directed exercise behaviour and important 
health outcomes in PwMS to nine months of follow-up.  
Methods: We conducted a parallel-arm, randomised controlled trial: 120 PwMS 
(Expanded Disability Status Scale (EDSS) 1.0–6.5) randomised to a three-month 
exercise intervention plus usual care, or usual care only. Two supervised plus one 
home-exercise session (weeks 1–6) were followed by one supervised and two home-
exercise sessions (weeks 7–12). Cognitive-behavioural techniques promoted long-term 
exercise behaviour change. Outcomes were blindly assessed at baseline and at three 
and nine months after randomisation. The primary outcome was self-reported exercise 
behaviour (Godin Leisure Time Exercise Questionnaire (GLTEQ)). Secondary 
outcomes included fatigue and health-related quality of life (HRQoL).  
Results: The intervention increased self-reported exercise (9.6 points; 95% CI: 2.0 to 
17.3 points; p = 0.01) and improved fatigue (p < 0.0001) and many HRQoL domains (p 
? 0.03) at three months. The improvements in emotional well-being (p = 0.01), social 
function (p = 0.004) and overall quality of life (p = 0.001) were sustained for nine 
months.  
Conclusion: This pragmatic approach to implementing exercise increases self-reported 
exercise behaviour, improves fatigue and leads to a sustained enhancement of HRQoL 
domains in PwMS. 
 
 
 
Introduction 
Supervised facility-based exercise programmes can offer comprehensive support and 
guidance for people with multiple sclerosis (PwMS) but over the long term are likely to 
prove difficult because of time barriers, transport issues and health constraints (e.g. 
fatigue).1 A major challenge is to develop pragmatic and cost-effective exercise 
programmes that can safely engage PwMS in exercise and provide robust evidence of 
a long-lasting impact on important health outcomes. Interventions that promote and 
provide support for sustainable home-based exercise, including use of community 
facilities, may help to overcome some of these problems but, to date, only very few 
studies have assessed the health impacts of exercise in community-based settings.2⇓–
4 The inclusion of cognitive-behavioural strategies might also be effective for 
increasing confidence for self-directed exercise, as reported in other clinical 
populations.5⇓–7  
Here, we report the effects of a pragmatic EXercise Intervention for people with MS 
(EXIMS) on self-directed exercise behaviour and important health outcomes, including 
fatigue and health-related quality of life (HRQoL). We hypothesised that participants 
randomised to the intervention group (EXIMS) would show an increase in physical 
activity levels and improvements in a range of health outcomes up to nine months of 
follow-up in comparison with participants randomised to usual care alone. 
 
Materials and Methods 
Controlled Trial  
This was a two-arm, parallel, randomised controlled trial. PwMS were randomised (1:1) 
to receive either the EXIMS intervention plus usual care or usual care only. Full details 
of the protocol have been published previously.8 This study was approved by the 
South Yorkshire Research Ethics Committee and conducted according to the principles 
of the Declaration of Helsinki. Written informed consent was obtained from participants 
before entering the study.  
 
Recruitment of participants and baseline assessment  
A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community 
adverts displayed at the local South Yorkshire MS Society branches. All patients were 
assessed by a consultant neurologist with an interest in MS prior to entering the trial. 
The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the 
modified McDonald criteria,9 with an Expanded Disability Status Scale (EDSS) score of 
1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at 
least four weeks prior to entering the study; physically able to participate in exercise 
three times per week; able to provide written informed consent. Participants on 
disease-modifying therapy (interferon beta, glatiramer acetate and natalizumab) had 
been stable on this treatment for at least three months. Exclusion criteria were 
comorbid conditions impairing the ability to be physically active three times per week; 
unwilling to be randomised; living more than 20 miles from the trial centre; already 
engaged in structured exercise or brisk walking ? 3 times per week for ? 30 minutes 
per session for at least six months.  
 
Randomisation and concealed allocation  
Minimisation was used to balance the potentially confounding variables of gender and 
EDSS score (low: 1.0–3.5; higher: 4.0–6.5). Treatment allocation was concealed from 
the study researchers by using a distant randomisation service at the University of 
York, UK. The allocation was not disclosed to members of the research team until 
participants had completed their baseline assessments. Due to the nature of the 
intervention, neither the participants nor researchers involved in the day-to-day running 
of the trial could be blinded to treatment allocation.  
 
Pragmatic exercise intervention  
An exercise physiologist supervised the delivery of the intervention but with 
physiotherapist input during the early stages of the programme. During weeks 1–6, 
participants attended two supervised sessions per week at a university exercise 
research facility and engaged in one additional self-directed exercise session in their 
home environment. Supervised exercise sessions involved up to three participants and 
lasted for approximately one hour. Studies show that aerobic exercise, resistance 
exercise and combined programmes bring health benefits to PwMS.10,11 Hence, the 
programme was designed to be pragmatic and accessible, taking into account exercise 
preferences and giving choices. Aerobic exercise was the core exercise modality as it 
is accessible (i.e. includes community-based walking exercise) and does not require 
equipment. Participants were asked to complete short bouts (e.g. 5 × 3 minutes, with 
two-minute rest intervals) of low to moderate intensity aerobic exercise (e.g. stepping 
ergometer, cycle-ergometer, treadmill walking, rowing ergometer, arm-cranking) at 
50%–69% of predicted maximum heart rate (220–age) or 12–14 on the Borg Ratings of 
Perceived Exertion Scale.12 Intensity was monitored continuously during exercise 
training sessions. As the intervention progressed, participants were encouraged to 
participate in longer periods of aerobic exercise (e.g. 5 × 4 minutes) or to take shorter 
rests between bouts.  
 
Where appropriate, participants also performed exercises for strength and control. The 
prescribed strength training was based on individual functional needs, as assessed by 
the trial physiotherapist (NS). Strength training was undertaken by 48 of 60 participants 
in the intervention group and typically involved two to six different resistance exercises 
(e.g. wall press-ups, arm-curls, leg abduction, wall squats and/or regular squats, knee 
extensions, calf raises, sit-to-stand) each session. Body resistance, light weights and 
Therabands were used to provide resistance and one to three sets of five to 20 
repetitions were performed, depending on level of disability and strength, as well as 
stage of the programme (exercises were progressed according to individual capabilities 
and strength gains). Balance board, balance exercises and exercise ball work were 
included where control and coordination were a problem and static stretching exercises 
for large skeletal muscle groups were also included in the sessions if appropriate.  
 
During weeks 7–12 participants attended the centre once per week and completed two 
additional self-directed exercise sessions in their home or local community. The home-
exercise sessions were intended to mirror the supervised sessions in terms of intensity 
and duration of aerobic exercise, and also included tailored exercises for strength, 
flexibility and balance. Participants were encouraged to seek out opportunities to 
exercise in the local community (e.g. healthy living centres, health walks, fitness 
centres, swimming pools, etc.), based on their individual preferences. Details of 
supervised and home-exercise sessions were recorded in an exercise log.  
 
The supervised exercise sessions incorporated cognitive-behavioural techniques (e.g. 
goal setting, finding social support, understanding the costs/benefits of exercise, etc.) 
to promote long-term participation in physical activity. Using the Transtheoretical 
Model13 as a guiding framework, this aspect of the intervention was aimed at 
equipping PwMS with the skills, knowledge and confidence to engage in a more 
physically active lifestyle. The cognitive-behavioural elements were integrated into the 
exercise sessions using strategies appropriate to the conversation, stage of change 
and concerns/questions raised by participants. Further details of the theoretical model 
for facilitating physical activity behaviour change have been published previously.8 
Participants in the usual care group were offered three exercise sessions at the 
university exercise research facility and individual exercise advice after the study.  
 
Outcome measures  
Outcomes were assessed at baseline, and at three months (post-intervention) and nine 
months after randomisation. The primary outcome was self-reported exercise 
behaviour at three months using the Godin Leisure Time Exercise Questionnaire 
(GLTEQ).14 The GLTEQ asks participants to recall the frequency of strenuous, 
moderate and mild intensity exercise for periods >15 minutes over the past seven days 
and is a valid measure of habitual exercise in PwMS.15 Daily movement and step 
counts were objectively assessed using an accelerometer (Actigraph GT2M 
accelerometer, Actigraph, LLC, FL, USA), worn on the waist during waking hours, 
except when bathing/showering or swimming. Accelerometers were programmed for an 
epoch length of one minute and the average daily movement count (vertical axis) and 
daily step count over a seven-day period were recorded.  
 
Secondary outcomes included fatigue, HRQoL, functional ability and neurological 
impairment. Fatigue was assessed using the Modified Fatigue Impact Scale (MFIS).16 
HRQoL was measured using the MSQoL-54.17 The Multiple Sclerosis Functional 
Composite (MSFC)18 was used as a measure of clinical functional ability. It includes a 
timed 25-foot walk and measures of arm/hand function (9-hole peg test) and cognitive 
function (Paced Auditory Serial Addition Test: PASAT). Functional exercise capacity 
was assessed using the six-minute walk test (6MWT).19 The EDSS20 (neurological 
impairment and disability) was assessed by a single trained consultant neurologist 
according to standard clinical procedures21 in the hospital setting. Other outcomes 
were blindly assessed by an experienced researcher not directly involved with the day-
to-day running of the trial.  
 
Sample size  
The sample size estimation was based on self-reported physical activity data (GLTEQ) 
from our pilot study.22 It was estimated that a sample of 50 patients for each group 
would be sufficient to detect a moderate effect size difference (80% power and a 5% 
significance level) in GLTEQ (standard deviation, SD = 2.29). Hence, we aimed to 
recruit 60 participants for each group to allow for a 15% loss to follow-up at the primary 
time point (based on our pilot study data).22  
 
Statistical analysis  
Repeated-measures mixed modelling was used to compare outcomes between the 
randomised groups at the three- and nine-month follow-ups, adjusting for baseline 
score, EDSS and gender. The distribution of the majority of outcomes were skewed, 
therefore the analyses were bootstrapped (1000 replications) to provide more reliable 
estimates. All analyses were by intention to treat, whereby participants were analysed 
in the arm to which they were randomised irrespective of whether they complied with 
the intervention. Multiple imputation of missing values was performed using the 
imputation by chained equations (ICE) command in Stata 12. Variables included in the 
imputation were age, gender, baseline EDSS, and baseline, three- and nine-month 
follow-up scores for all outcomes. Five imputations were carried out and mixed-model 
analysis was performed on each imputed dataset. The adjusted means and confidence 
intervals (CIs) from each analysis were then consolidated using Rubin’s rules. 
Sensitivity analysis was performed to determine the effect of outliers in the GLTEQ 
scores by their removal from the analysis. Bivariate associations between key variables 
were analysed using the Pearson Product Moment correlation coefficient. No 
corrections for multiple testing were made in the analysis. Analyses were undertaken 
by the trial statistician, blinded to treatment allocation, using STATA 12 and results are 
generally reported as means and CIs. 
 
Results 
Table 1. Baseline characteristics of participants allocated to usual care only or usual 
care plus EXIMS. Values are numbers (percentages) or mean ± SD.  
 
 
Participant flow and recruitment  
The trial took place from March 2009 to August 2012. Of 349 potential participants who 
were assessed for eligibility, 120 (34%) were randomised (Figure 1). The two groups 
had similar demographic, anthropometric and MS disease characteristics at baseline 
(Table 1). In the two years preceding the study, 55 relapses were experienced by 30 
participants in the usual care group in comparison to 54 relapses experienced by 33 
participants in the exercise group.  
 
 
Figure 1. Flow of participants through the trial. EXIMS: pragmatic EXercise 
Intervention for people with MS. 
 
 
Loss to follow-up and MS relapses  
A total of 13 participants (six from the intervention group and seven from the usual care 
group) were lost to follow-up at three months. An additional eight participants were lost 
to follow-up at nine months (five from the intervention group and three from the usual 
care group; Figure 1). Participants that dropped out of the study were slightly younger 
than the study completers (43.3 vs 46.3 years) and had higher baseline EDSS and total 
fatigue scores (4.5 vs 3.6 and 48.0 vs 42.6, respectively). During the nine-month study 
period, 16 MS relapses were experienced by 14 of the usual care participants in 
comparison to 10 MS relapses experienced by nine participants in the exercise group. 
Participants were encouraged to rejoin the trial following recovery, and complete or 
partial follow-up data were obtained for 21 of the 23 relapsing participants. 
  
 
Figure 2. Minutes of supervised and home-based aerobic exercise achieved by the 
intervention group at different intensities over the supervised period of the study 
(weeks 1–12). Values are means with error bars representing 95% confidence 
intervals. RPE: Ratings of Perceived Exertion. 
 
Table 2. Baseline primary and secondary outcome data for participants allocated to 
usual care only and usual care plus EXIMS. Values are presented as mean ± SD. 
 
 
Adherence to the EXIMS intervention  
Adherence to the supervised and home-exercise sessions was very good, with 
participants attending an average of 16.2 of the 18 supervised sessions (90%; range 
7–18 sessions) and participating in an average of 14.6 of the 18 prescribed home-
exercise sessions (81%, range 2–18 sessions). Home exercise during the intervention 
period comprised walking, use of home exercise equipment, public facilities (including 
swimming) and gardening for the majority of participants. The volumes of supervised 
and home-based aerobic exercise are presented in Figure 2. No serious adverse 
events or serious symptom exacerbations were recorded. 
 
Figure 3. Adjusted mean differences in self-reported exercise (GLTEQ) and 
accelerometry step counts between the intervention and usual care control groups at 3 
months and 9 months (adjusted for baseline, gender and EDSS). Values are means 
with error bars representing 95% confidence intervals. **p?0.01 between the groups.  
GLTEQ: Godin Leisure Time Exercise Questionnaire. 
 
Primary and secondary outcomes  
Baseline scores for the primary and secondary outcomes were comparable for the two 
groups (Table 2). An increase in GLTEQ was observed in the exercise group versus 
usual care at the primary time point of three months (p = 0.01) and a non-significant 
increase was still apparent after nine months (p = 0.08; Figure 3). The improvement in 
self-reported exercise behaviour was accompanied by increases in objectively 
measured daily step counts at three months (p = 0.009) in the exercise group versus 
usual care, but at nine months daily step counts were similar to baseline levels (Figure 
3). All dimensions of fatigue were significantly improved in the exercise group in 
comparison with usual care at three months (p <0.0001), with the change in total 
fatigue scores being positively correlated with baseline levels (Table 3). Interestingly, 
volume of supervised aerobic exercise achieved was negatively correlated with the 
change in total fatigue scores at the three-month follow-up (Table 3). The 
improvements in fatigue were not maintained at nine months (Table 4). Positive 
changes in many quality of life domains in favour of the exercise group were also 
observed at three months, with improvements in emotional well-being (p = 0.01), social 
function (p = 0.004) and overall quality of life (p = 0.001) being maintained for nine 
months (Table 4). The exercise intervention had no effect on functional ability or 
neurological impairment (Table 4). At baseline, EDSS scores were positively correlated 
with total fatigue scores and negatively correlated with the volume of aerobic exercise 
achieved (Table 3). Body weight also remained unchanged in both groups but there 
was evidence of a reduction in waist circumference at both follow-up time points (non-
significant at three months) and reduction in diastolic blood pressure at nine months in 
the exercise group versus usual care (Table 5). Multiple imputation analysis gave 
similar results to the primary available case analyses, and exclusion of outliers in 
GLTEQ scores had no impact. 
Table 3. Bivariate association between EDSS, total fatigue, GLTEQ and total volumes 
of supervised and home-based aerobic exercise for the intervention group. 
 
Table 4. Secondary outcomes at three months and nine months in participants 
allocated to usual care and usual care plus EXIMS. 
 
 
Table 5. Anthropometric, blood pressure and EDSS scores at three- and nine-month 
follow-ups in participants allocated to usual care only and usual care plus EXIMS. 
 
Discussion 
This was the first robustly designed randomised controlled trial to investigate the 
effects of a practically implemented progressive exercise programme on self-directed 
exercise behaviour and important health outcomes in PwMS up to nine months of 
follow-up. Significant increases in self-reported exercise behaviour (GLTEQ) and step 
counts were observed in the intervention group versus controls at three months. A 
smaller difference in GLTEQ score (6.9 points, 95% CI: –0.9 to 14.7) in favour of the 
intervention group was also apparent after nine months, though this was not 
statistically significant and there was no evidence of a sustained increase in step 
counts at this time point.  
Whilst the GLTEQ is reported to be a valid measure of habitual exercise behaviour in 
PwMS,15 the possibility that self-reporting bias explains the discrepancy between 
GLTEQ scores and accelerometry step counts at nine months cannot be overlooked. 
However, difficulties interpreting accelerometer step-count data in PwMS have been 
highlighted,23 and activities such as stationary cycling, seated upper-body exercise, 
gardening and swimming can go undetected when using accelerometry. Although body 
weight remained unchanged, evidence of a reduction in waist circumference at both 
follow-up time points (non-significant at three months) and the reduction in diastolic 
blood pressure at nine months provides support for the maintenance of physical activity 
in the exercise group. These findings also show that the exercise intervention had an 
important impact on risk factors for cardiovascular disease. Hence, the apparent 
discrepancy between GLTEQ score and accelerometry step counts may reflect a shift 
to predominantly undetectable non-ambulatory activities over the study follow-up 
period, but this needs to be verified by future research. Despite this, our results 
suggest that the magnitude of change in self-directed exercise behaviour at nine 
months was reduced and was less clinically relevant.  
The exercise group experienced improvements in multidimensional fatigue and in most 
HRQoL dimensions at three months. These improvements are consistent with previous 
systematic reviews,24,25 although some conflicting evidence also exists.26,27 Fatigue 
negatively affects HRQoL28 and has a major impact on the high levels of 
unemployment in PwMS,29 with ?75% of the MS population experiencing symptoms 
persistently or sporadically.30 For these reasons, pragmatic interventions that can 
alleviate fatigue are likely to have an important impact on HRQoL and ability to remain 
in employment. Baseline fatigue scores in the exercise group were positively 
associated with EDSS scores at baseline and the reduction in symptoms observed at 
the three-month follow-up. This suggests that PwMS experiencing the highest levels of 
fatigue also experienced the greatest improvements with exercise training. However, 
higher volumes of supervised aerobic exercise were associated with less pronounced 
reductions in fatigue, suggesting that there could be an optimum level of aerobic 
exercise for symptom relief in PwMS. The changes in fatigue and GLTEQ scores were 
unrelated.  
Improvements in emotional well-being, social function and overall HRQoL were 
maintained to nine months in the exercise group (versus controls), whereas the 
difference between groups in other HRQoL domains and fatigue was diminished at the 
final follow-up. The lack of a sustained improvement in other HRQoL domains and 
fatigue might be explained by a reduction in self-directed exercise over the follow-up 
period. Although previous studies suggest that short-term exercise interventions can 
have lasting effects on fatigue and HRQoL up to three months,2,31,32 continued 
engagement in exercise is likely to be needed for the longer-term enhancement of 
many HRQoL dimensions and MS fatigue. A higher level of contact with participants 
after the intervention period could have been used to provide additional support and 
motivation for self-directed exercise. Although this has resource implications, our 
results suggest that strategies for maintaining contact with participants after an initial 
period of supervision (e.g. posted literature, mobile phone text messaging, social 
media, etc.) warrant further investigation.  
There were no changes in measures of functional ability (6MWT) or neurological 
impairment (EDSS and MSFC) and these results are consistent with 
some4,26,31,33,34 but not all previous exercise intervention studies.3,26,27 Evidence 
suggests that regular exercise may be more effective in retarding disease progression 
in PwMS,35 rather than reversing the neuropathological changes that underpin 
neurological and functional impairments.36  
A key limitation of the study is that it included ambulatory participants with only mild to 
moderate disease (EDSS ? 6.5) and at the present time, the effectiveness of exercise 
interventions for people with more severe disability is unknown. Many eligible PwMS 
declined to take part in the study without giving a reason (N = 126; 66%) and a more 
comprehensive understanding of the barriers and facilitators to exercise in PwMS could 
be used to inform the design of future programmes. In the remaining 34%, 
unwillingness to travel, other commitments, not being interested in exercise and 
worries about losing welfare benefits were cited as the reasons for not taking part. At 
least 30 potentially eligible PwMS considered the distance too far to travel (Figure 1), 
hence, providing the supervised component in a broader range of community settings 
may help to engage more PwMS in exercise programmes.  
In conclusion, the observed improvements in self-directed exercise behaviour, HRQoL 
and fatigue suggest that EXIMS could be an effective way to practically implement 
progressive exercise rehabilitation within health care settings. EXIMS provides a 
tailored programme of preferred supervised and home-based exercises that are 
appropriate for individuals with different physical abilities and the level of uptake (39%) 
and high level of adherence (>80%) provides evidence that it is accessible to many 
PwMS. This study recruited participants with a range of neurological impairment 
(EDSS: 1.0–6.5), suggesting the results can be generalised to a broad spectrum of 
ambulatory PwMS. Strategies for promoting continued contact between participants 
and exercise practitioners beyond the initial period of supervision, however, may be 
needed to maintain meaningful improvements in important health outcomes.  
 
Acknowledgments 
We wish to thank Robert Scaife (Centre for Sport and Exercise Science, Sheffield 
Hallam University) for conducting the blind assessment of outcomes and Linda Nichols 
(Primary Care Clinical Research & Trials Unit, University of Birmingham) for her 
assistance with data analysis. 
 
References 
1. Asano M, Duquette P, Andersen R, et al. Exercise barriers and preferences among 
women and men with multiple sclerosis. Disabil Rehabil 2013; 35: 353–361. 
2. Garrett M, Hogan N, Larkin A, et al. Exercise in the community for people with 
multiple sclerosis – a follow-up of people with minimal gait impairment. Mult Scler 2013; 
19: 790–798. 
3. Garrett M, Hogan N, Larkin A, et al. Exercise in the community for people with 
minimal gait impairment due to MS: An assessor-blind randomized controlled trial. Mult 
Scler 2013; 19: 782–789.  
4. Learmonth YC, Paul L, Miller L, et al. The effects of a 12-week leisure centre-based, 
group exercise intervention for people moderately affected with multiple sclerosis: A 
randomized controlled pilot study. Clin Rehabil 2012; 26: 579–593.  
5. Daley AJ, Crank H, Saxton JM, et al. Randomized trial of exercise therapy in women 
treated for breast cancer. J Clin Oncol 2007; 25: 1713–1721.  
6. Bourke L, Thompson G, Gibson DJ, et al. Pragmatic lifestyle intervention in patients 
recovering from colon cancer: A randomized controlled pilot study. Arch Phys Med 
Rehabil 2011; 92: 749–755.  
7. Kirk A, Mutrie N, MacIntyre P, et al. Effects of a 12-month physical activity 
counselling intervention on glycaemic control and on the status of cardiovascular risk 
factors in people with type 2 diabetes. Diabetologia 2004; 47: 821–832.  
8. Saxton JM, Carter A, Daley AJ, et al. Pragmatic exercise intervention for people with 
multiple sclerosis (EXIMS Trial): Study protocol for a randomised controlled trial. 
Contemp Clin Trials 2012; 34: 205–211.  
9. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 
2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292–302. 
10. Rietberg MB, Brooks D, Uitdehaag BM, et al. Exercise therapy for multiple 
sclerosis. Cochrane Database Syst Rev 2005; CD003980. 
11. Latimer-Cheung AE, Pilutti LA, Hicks AL, et al. The effects of exercise training on 
fitness, mobility, fatigue and health-related quality of life among adults with multiple 
sclerosis: A systematic review to inform guideline development. Arch Phys Med 
Rehabil 2013; 94: 1800–1828.  
12. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 
1970; 2: 92–98.  
13. Prochaska JO, Diclemente CC. Stages and processes of self-change of smoking: 
Toward an integrative model of change. J Consult Clin Psychol 1983; 51: 390–395.  
14. Godin G, Shephard RJ. A simple method to assess exercise behavior in the 
community. Can J Appl Sport Sci 1985; 10: 141–146.  
15. Motl RW, McAuley E, Snook EM, et al. Validity of physical activity measures in 
ambulatory individuals with multiple sclerosis. Disabil Rehabil 2006; 28: 1151–1156. 
16. Fisk JD, Ritvo PG, Ross L, et al. Measuring the functional impact of fatigue: Initial 
validation of the Fatigue Impact Scale. Clin Infect Dis 1994; 18 (Suppl 1): S79-S83.  
17. Vickrey BG, Hays RD, Harooni R, et al. A health-related quality of life measure for 
multiple sclerosis. Qual Life Res 1995; 4: 187–206.  
18. National Multiple Sclerosis Society. Multiple Sclerosis Functional Composite: 
Administration and Scoring Manual, 2001. http://www.nationalmssociety.org/ms-
clinical-care-network/researchers/clinical-study-measures/msfc/index.aspx (accessed 
October 1, 2013).    
19. ATS Committee on Proficiency Standards for Clinical Pulmonary Function 
Laboratories. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit 
Care Med 2002; 166: 111–117.  
20. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded 
disability status scale (EDSS). Neurology 1983; 33: 1444–1452.  
21. Neurostatus.net. Independent Internet platform for training and certification of 
physicians participating in projects that use a standardised, quantified neurological 
examination and assessment of Kurtzke’s functional systems and Expanded Disability 
Status Scale in multiple sclerosis, http://www.neurostatus.net/Index.php (2013, 
accessed October 1, 2013).    
22. Carter A, Daley AJ, Kesterton SW, et al. Pragmatic exercise intervention in people 
with mild to moderate multiple sclerosis: A randomized controlled feasibility study. 
Contemp Clin Trials 2013; 35: 40–47.  
23. Weikert M, Motl RW, Suh Y, et al. Accelerometry in persons with multiple sclerosis: 
Measurement of physical activity or walking mobility? J Neurol Sci 2010; 290: 6–11.  
24. Motl RW, Gosney JL. Effect of exercise training on quality of life in multiple 
sclerosis: A meta-analysis. Mult Scler 2008; 14: 129–135. 
25. Andreasen AK, Stenager E, Dalgas U. The effect of exercise therapy on fatigue in 
multiple sclerosis. Mult Scler 2011; 17: 1041–1054.  
26. Rampello A, Franceschini M, Piepoli M, et al. Effect of aerobic training on walking 
capacity and maximal exercise tolerance in patients with multiple sclerosis: A 
randomized crossover controlled study. Phys Ther 2007; 87: 545–555.  
27. Romberg A, Virtanen A, Ruutiainen J. Long-term exercise improves functional 
impairment but not quality of life in multiple sclerosis. J Neurol 2005; 252: 839–845.  
28. Amato MP, Ponziani G, Rossi F, et al. Quality of life in multiple sclerosis: The 
impact of depression, fatigue and disability. Mult Scler 2001; 7: 340–344.  
29. Smith MM, Arnett PA. Factors related to employment status changes in individuals 
with multiple sclerosis. Mult Scler 2005; 11: 602–609.  
30. Lerdal A, Celius EG, Krupp L, et al. A prospective study of patterns of fatigue in 
multiple sclerosis. Eur J Neurol 2007; 14: 1338–1343.  
31. Dalgas U, Stenager E, Jakobsen J, et al. Fatigue, mood and quality of life improve 
in MS patients after progressive resistance training. Mult Scler 2010; 16: 480–490.  
32. McCullagh R, Fitzgerald AP, Murphy RP, et al. Long-term benefits of exercising on 
quality of life and fatigue in multiple sclerosis patients with mild disability: A pilot study. 
Clin Rehabil 2008; 22: 206–214.   
33. Petajan JH, Gappmaier E, White AT, et al. Impact of aerobic training on fitness and 
quality of life in multiple sclerosis. Ann Neurol 1996; 39: 432–441.  
34. Pilutti LA, Lelli DA, Paulseth JE, et al. Effects of 12 weeks of supported treadmill 
training on functional ability and quality of life in progressive multiple sclerosis: A pilot 
study. Arch Phys Med Rehabil 2011; 92: 31–36. 
35. Stuifbergen AK, Blozis SA, Harrison TC, et al. Exercise, functional limitations, and 
quality of life: A longitudinal study of persons with multiple sclerosis. Arch Phys Med 
Rehabil 2006; 87: 935–943.  
36. Dalgas U, Stenager E. Exercise and disease progression in multiple sclerosis: Can 
exercise slow down the progression of multiple sclerosis? Ther Adv Neurol Disord 
2012; 5: 81–95.  
